These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34152756)

  • 1. Selective Pseudo-irreversible Butyrylcholinesterase Inhibitors Transferring Antioxidant Moieties to the Enzyme Show Pronounced Neuroprotective Efficacy In Vitro and In Vivo in an Alzheimer's Disease Mouse Model.
    Scheiner M; Hoffmann M; He F; Poeta E; Chatonnet A; Monti B; Maurice T; Decker M
    J Med Chem; 2021 Jul; 64(13):9302-9320. PubMed ID: 34152756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer's disease.
    Singh YP; Shankar G; Jahan S; Singh G; Kumar N; Barik A; Upadhyay P; Singh L; Kamble K; Singh GK; Tiwari S; Garg P; Gupta S; Modi G
    Bioorg Med Chem; 2021 Sep; 46():116385. PubMed ID: 34481338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment.
    Makhaeva GF; Lushchekina SV; Kovaleva NV; Yu Astakhova T; Boltneva NP; Rudakova EV; Serebryakova OG; Proshin AN; Serkov IV; Trofimova TP; Tafeenko VA; Radchenko EV; Palyulin VA; Fisenko VP; Korábečný J; Soukup O; Richardson RJ
    Bioorg Chem; 2021 Jul; 112():104974. PubMed ID: 34029971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interest of novel N-alkylpyridinium-indolizine hybrids in the field of Alzheimer's disease: Synthesis, characterization and evaluation of antioxidant activity, cholinesterase inhibition, and amyloid fibrillation interference.
    Baussanne I; Firstova O; Dediu AB; Larosa C; Furdui B; Ghinea IO; Thomas A; Chierici S; Dinica R; Demeunynck M
    Bioorg Chem; 2021 Nov; 116():105390. PubMed ID: 34670332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Biological Activity of Some Benzochromenoquinolinones: Tacrine Analogs as Potent Anti-Alzheimer's Agents.
    Mahdavi M; Hariri R; Mirfazli SS; Lotfian H; Rastergari A; Firuzi O; Edraki N; Larijani B; Akbarzadeh T; Saeedi M
    Chem Biodivers; 2019 Apr; 16(4):e1800488. PubMed ID: 30720917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro evaluation of vanillin derivatives as multi-target therapeutics for the treatment of Alzheimer's disease.
    Blaikie L; Kay G; Kong Thoo Lin P
    Bioorg Med Chem Lett; 2020 Nov; 30(21):127505. PubMed ID: 32822761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of novel xanthone-alkylbenzylamine hybrids as multifunctional agents for the treatment of Alzheimer's disease.
    Zhang Z; Guo J; Cheng M; Zhou W; Wan Y; Wang R; Fang Y; Jin Y; Liu J; Xie SS
    Eur J Med Chem; 2021 Mar; 213():113154. PubMed ID: 33476932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and evaluation of cinnamic acid hybrids as multi-target-directed agents for the treatment of Alzheimer's disease.
    Wang K; Shi J; Zhou Y; He Y; Mi J; Yang J; Liu S; Tang X; Liu W; Tan Z; Sang Z
    Bioorg Chem; 2021 Jul; 112():104879. PubMed ID: 33915461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of naringenin-O-carbamate derivatives as multi-target-directed liagnds for the treatment of Alzheimer's disease.
    Mi J; He Y; Yang J; Zhou Y; Zhu G; Wu A; Liu W; Sang Z
    Bioorg Med Chem Lett; 2022 Mar; 60():128574. PubMed ID: 35065231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel cinnamamide-dibenzylamine hybrids: Potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer's disease.
    Wang J; Cai P; Yang XL; Li F; Wu JJ; Kong LY; Wang XB
    Eur J Med Chem; 2017 Oct; 139():68-83. PubMed ID: 28800459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamine.
    Huang G; Kling B; Darras FH; Heilmann J; Decker M
    Eur J Med Chem; 2014 Jun; 81():15-21. PubMed ID: 24819955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
    Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
    Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties.
    Cai P; Fang SQ; Yang HL; Yang XL; Liu QH; Kong LY; Wang XB
    Eur J Med Chem; 2018 Sep; 157():161-176. PubMed ID: 30096650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, bioactivity and molecular modeling studies on potential anti-Alzheimer piperidinehydrazide-hydrazones.
    Parlar S; Sayar G; Tarikogullari AH; Karadagli SS; Alptuzun V; Erciyas E; Holzgrabe U
    Bioorg Chem; 2019 Jun; 87():888-900. PubMed ID: 30538051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological evaluation of novel (4-(1,2,4-oxadiazol-5-yl)phenyl)-2-aminoacetamide derivatives as multifunctional agents for the treatment of Alzheimer's disease.
    Liu T; Chen S; Du J; Xing S; Li R; Li Z
    Eur J Med Chem; 2022 Jan; 227():113973. PubMed ID: 34752955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional tacrine-trolox hybrids for the treatment of Alzheimer's disease with cholinergic, antioxidant, neuroprotective and hepatoprotective properties.
    Xie SS; Lan JS; Wang XB; Jiang N; Dong G; Li ZR; Wang KD; Guo PP; Kong LY
    Eur J Med Chem; 2015 Mar; 93():42-50. PubMed ID: 25656088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of naringenin-
    Yang J; Zhou Y; Ban Y; Mi J; He Y; Li X; Liu Z; Wang K; Zhu G; Liu W; Tan Z; Sang Z
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):792-816. PubMed ID: 35193434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation, identification, and quantification of Pentylcurcumene from Geophila repens: A new class of cholinesterase inhibitor for Alzheimer's disease.
    Dash UC; Kanhar S; Dixit A; Dandapat J; Sahoo AK
    Bioorg Chem; 2019 Jul; 88():102947. PubMed ID: 31028989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acylhydrazones as isoniazid derivatives with multi-target profiles for the treatment of Alzheimer's disease: Radical scavenging, myeloperoxidase/acetylcholinesterase inhibition and biometal chelation.
    Santos DC; Henriques RR; Junior MAAL; Farias AB; Nogueira TLDC; Quimas JVF; Romeiro NC; Silva LLD; Souza ALF
    Bioorg Med Chem; 2020 May; 28(10):115470. PubMed ID: 32278712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel salicylamide derivatives as potent multifunctional agents for the treatment of Alzheimer's disease: Design, synthesis and biological evaluation.
    Song Q; Li Y; Cao Z; Qiang X; Tan Z; Deng Y
    Bioorg Chem; 2019 Mar; 84():137-149. PubMed ID: 30500523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.